quantisnow
FeedTopReportsPricing
⌘K
Live feed
00:15:03·408d
SECFiling
Syros Pharmaceuticals Inc. logo

SEC Form EFFECT filed by Syros Pharmaceuticals Inc.

SYRS· Syros Pharmaceuticals Inc.
Health Care
Original source

Companies

  • SYRS
    Syros Pharmaceuticals Inc.
    Health Care

Recent analyst ratings

  • Sep 23UpdateRoth Capital$23.00

Related

  • PR374d
    Rege Nephro Acquires Tamibarotene-Related Assets from Syros Pharmaceuticals for U.S. Clinical Trials
  • SEC399d
    SEC Form 15-12G filed by Syros Pharmaceuticals Inc.
  • SEC405d
    SEC Form 144 filed by Syros Pharmaceuticals Inc.
  • SEC408d
    SEC Form EFFECT filed by Syros Pharmaceuticals Inc.
  • SEC408d
    SEC Form EFFECT filed by Syros Pharmaceuticals Inc.
  • SEC408d
    SEC Form EFFECT filed by Syros Pharmaceuticals Inc.
  • SEC408d
    SEC Form EFFECT filed by Syros Pharmaceuticals Inc.
  • SEC408d
    SEC Form EFFECT filed by Syros Pharmaceuticals Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022